China NT Pharma Group Co (HKSE:01011) 3-Year EBITDA Growth Rate : 0.00% (As of Jun. 2024)

View and export this data going back to 2011. Start your Free Trial

What is China NT Pharma Group Co 3-Year EBITDA Growth Rate?

China NT Pharma Group Co's EBITDA per Share for the six months ended in Jun. 2024 was HK$0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of China NT Pharma Group Co was 67.10% per year. The lowest was -33.30% per year. And the median was 15.30% per year.

Competitive Comparison of China NT Pharma Group Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, China NT Pharma Group Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China NT Pharma Group Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China NT Pharma Group Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where China NT Pharma Group Co's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

China NT Pharma Group Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

China NT Pharma Group Co (HKSE:01011) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

China NT Pharma Group Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of China NT Pharma Group Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

China NT Pharma Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China NT Pharma Group Co Ltd (HKSE:01011) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

198 Wellington Street, 28th Floor, The Wellington, Sheung Wan, Hong Kong, HKG

Website

http://www.ntpharma.com

China NT Pharma Group Co Ltd is a technology-based pharmaceutical company. It is engaged in research and development, production, and sale of private-label drugs, as well as the provision of pharmaceutical marketing and promotion services in China. It focused on the research, development, production, and sales of orthopedic, psychiatric, and oncology drugs. The company operates in a single segment of Proprietary product production and sales. The company earns the majority of its revenue from the domestic market. The Group's revenue from an external customer was derived solely from its operations in the PRC.

Executives

Ieong Chong Mang
Golden Base Investment Limited
Wang Minzhi	2101 Beneficial owner
Shum Ning
Chin Yu
Ng Tit
Ieong Iat	2101 Beneficial owner

China NT Pharma Group Co Headlines

No Headlines